
1. viruses. 2018 nov 12;10(11). pii: e623. doi: 10.3390/v10110623.

following footsteps chikungunya virus brazil: first
autochthonous cases amapá 2014 emergence rio de janeiro during
2016.

de souza tma(1), ribeiro ed(2), corrêa vce(3), damasco pv(4)(5)(6), santos cc(7),
de bruycker-nogueira f(8), chouin-carneiro t(9), faria nrdc(10), nunes pcg(11),
heringer m(12), lima mdrq(13), badolato-corrêa j(14), cipitelli mdc(15), azeredo 
el(16), nogueira rmr(17), dos santos fb(18).

author information: 
(1)viral immunology laboratory, oswaldo cruz institute, 21040-360 rio de janeiro,
brazil. thiara.biomed@gmail.com.
(2)laboratório central /amapa (lacen/ap), 68908-530 macapa, brazil.
edcelhamanu@hotmail.com.
(3)laboratório de fronteira (lafron), oiapoque, 69980-000 amapa, brazil.
biomedicocorrea@gmail.com.
(4)rio-laranjeiras hospital, 22240-000 rio de janeiro, brazil.
paulovieiradamasco@gmail.com.
(5)gaffrée guinle university hospital, federal university state rio de 
janeiro, 20270-003 rio de janeiro, brazil. paulovieiradamasco@gmail.com.
(6)pedro ernesto university hospital, university state rio de janeiro, 
20551-030 rio de janeiro, brazil. paulovieiradamasco@gmail.com.
(7)rio-laranjeiras hospital, 22240-000 rio de janeiro, brazil. ccih@fblo.com.br.
(8)viral immunology laboratory, oswaldo cruz institute, 21040-360 rio de janeiro,
brazil. nandanog@ioc.fiocruz.br.
(9)viral immunology laboratory, oswaldo cruz institute, 21040-360 rio de janeiro,
brazil. tatachouin@gmail.com.
(10)viral immunology laboratory, oswaldo cruz institute, 21040-360 rio de
janeiro, brazil. nielircf@ioc.fiocruz.br.
(11)viral immunology laboratory, oswaldo cruz institute, 21040-360 rio de
janeiro, brazil. pricgn@ioc.fiocruz.br.
(12)viral immunology laboratory, oswaldo cruz institute, 21040-360 rio de
janeiro, brazil. manoelaheringer@yahoo.com.br.
(13)viral immunology laboratory, oswaldo cruz institute, 21040-360 rio de
janeiro, brazil. moniqueq@ioc.fiocruz.br.
(14)viral immunology laboratory, oswaldo cruz institute, 21040-360 rio de
janeiro, brazil. jessica.badolato@ioc.fiocruz.br.
(15)viral immunology laboratory, oswaldo cruz institute, 21040-360 rio de
janeiro, brazil. marcio_cipitelli@ioc.fiocruz.br.
(16)viral immunology laboratory, oswaldo cruz institute, 21040-360 rio de
janeiro, brazil. elzinandes@ioc.fiocruz.br.
(17)flavivirus laboratory, oswaldo cruz institute, 21040-360 rio de janeiro,
brazil. rita@ioc.fiocruz.br.
(18)viral immunology laboratory, oswaldo cruz institute, 21040-360 rio de
janeiro, brazil. flaviab@ioc.fiocruz.br.

currently, brazil lives triple arboviruses epidemic (denv, zikv chikv)
making differential diagnosis difficult health professionals. here, we
aimed investigate chikungunya cases possible occurrence of
co-infections epidemic amapá (ap) started 2014 the
first autochthonous cases reported rio de janeiro (rj) 2016. we
further performed molecular characterization genotyping representative
strains. ap, 51.4% suspected cases confirmed chikv, 71.0%
(76/107). those, 24 co-infections chikv/denv, two chikv/denv-1, two 
by chikv/denv-4 observed. rj, 76.9% suspected cases confirmed
for chikv co-infections chikv/denv (n = 8) chikv/zikv (n = 17) were
observed. overall, fever, arthralgia, myalgia, prostration, edema, exanthema,
conjunctival hyperemia, lower back pain, dizziness, nausea, retroorbital pain,
and anorexia predominating chikungunya clinical symptoms described. 
strains analyzed ap belonged asian genotype amino acid changes
were observed. rj, east-central-south-african genotype (ecsa) circulation 
was demonstrated e1-a226v mutation observed. despite this, e1-v156a
substitution characterized two samples first time, the
e1-k211t mutation reported samples analyzed.

doi: 10.3390/v10110623 
pmcid: pmc6266966
pmid: 30424530  [indexed medline]

